Company news

ENDRA Life Sciences Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue

December 22, 2020

ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years

December 20, 2020

ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option

December 17, 2020

ENDRA Life Sciences Granted Seventh Chinese Patent for its TAEUS(R) Platform Technology

December 14, 2020

ENDRA Life Sciences Announces Proposed Public Offering of Common Stock

December 14, 2020

ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock

December 14, 2020

ENDRA Life Sciences Signs First Distribution Agreement for TAEUS(R)

December 6, 2020

ENDRA Life Sciences Announces New Clinical Study Partnership with the Centre Hospitalier Universitaire d'Angers, France

December 2, 2020

ENDRA Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update

November 15, 2020

ENDRA Life Sciences Installs First TAEUS(R) System and Begins Scanning at Rocky Vista University

November 11, 2020

ENDRA Life Sciences to Showcase TAEUS(R) Technology at Two Upcoming Medical Meetings

November 10, 2020

ENDRA Life Sciences to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Monday, November 16, 2020 at 4: 30 p.m. ET

November 4, 2020

ENDRA Life Sciences Issued Fifth European Patent that Protects its TAEUS(R) Platform for Imaging Biological Tissue Structures

October 27, 2020

ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe

October 12, 2020

ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020

August 26, 2020

ENDRA Life Sciences to Receive $5 Million From Early Warrant Exercises

August 23, 2020

ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4: 30 p.m. ET

August 4, 2020

ENDRA Life Sciences Granted Additional European Patent As Commercialization Begins

July 21, 2020

ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents

July 12, 2020

ENDRA Life Sciences Submits 510(k) Application to the US FDA for TAEUS(R) Liver Device

June 29, 2020

ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents

June 22, 2020

ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin (MCW)

June 7, 2020

ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results

May 13, 2020

ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe

May 5, 2020

ENDRA Life Sciences to Host First Quarter 2020 Financial Results Conference Call and Webcast on Thursday, May 14, 2020 at 4: 30 p.m. ET

April 30, 2020

ENDRA Life Sciences Builds on CE Mark Approval

April 29, 2020

ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19

April 12, 2020

ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

March 25, 2020

ENDRA Life Sciences Provides Update on FDA Regulatory Timeline

March 18, 2020

ENDRA Life Sciences Provides European Commercialization Update

March 16, 2020

ENDRA Life Sciences Receives CE Mark for its TAEUS(R) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

March 9, 2020

ENDRA Life Sciences to Host Fourth Quarter 2019 Financial Results Conference Call and Webcast on Thursday, March 26, 2020 at 4: 30 p.m. ET

March 8, 2020

ENDRA Life Sciences Granted Chinese Patent for "Thermoacoustic Imaging Probe"

March 5, 2020

Dr. Raza Malik joins ENDRA Life Sciences as Scientific Advisor

March 2, 2020

ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement

January 14, 2020

ENDRA Life Sciences Completes $8.1 Million Private Placement

December 10, 2019

ENDRA Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results

November 12, 2019

ENDRA Life Sciences to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, November 13, 2019 at 4: 30 p.m. ET

November 4, 2019

ENDRA Life Sciences Reports Completion and Top Level Findings of Second Phase of Robarts Research Institute Liver Fat Feasibility Study

September 25, 2019

ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019

September 9, 2019

← Newer news releases

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 12 decks. Every deck is listed under its year.